Unsere Gruppe organisiert über 3000 globale Konferenzreihen Jährliche Veranstaltungen in den USA, Europa und anderen Ländern. Asien mit Unterstützung von 1000 weiteren wissenschaftlichen Gesellschaften und veröffentlicht über 700 Open Access Zeitschriften, die über 50.000 bedeutende Persönlichkeiten und renommierte Wissenschaftler als Redaktionsmitglieder enthalten.
Open-Access-Zeitschriften gewinnen mehr Leser und Zitierungen
700 Zeitschriften und 15.000.000 Leser Jede Zeitschrift erhält mehr als 25.000 Leser
Jin X, Hong Y, Li P, Hao L and Chen M
Several studies have demonstrated the dysregulation of miR-449b-5p in numerous types of human cancers. However, the understanding of the function of miR-449b-5p the mechanisms linking its expression to the development of colorectal cancer (CRC) remains limited. The current work documented the decrease in the level of miR-449b-5p in CRC tissues as well as in CRC-derived cell lines. Functional assays indicated that the overexpression of miR-449b-5p inhibits proliferation, migration, and invasion of CRC cells. Mechanistically, the direct target of miR-449b-5p in CRC cells was identified as the catenin delta 1 (CTNND1) protein. Increased level of miR-449b-5p in CRC cells downregulated β-catenin, WNT11, cyclin D1, and MMP7. Conversely, the restoration of CTNND1 expression abrogated the inactivation of Wnt/β-catenin signaling induced by miR-449b-5p. In conclusion, the present investigation demonstrates for the first time that miR-449b-5p is capable of inhibiting the progression of CRC. This effect is achieved, at least in part, by targeting CTNND1-mediated Wnt/β-catenin signaling. The accumulated data point to miR-449b-5p as a novel target in the treatment of CRC.